December 31st, 2021
Our GoFundMe is still live! The CS Foundation is committed to improving the treatment of patients living with this rare bone & soft tissue cancer. We are currently raising money for the development of a Patient Registry & Natural History…
Uncategorized Posts
December 22nd, 2021
This is a website we have created geared for educational purposes in bone and soft tissue pathology. A new series of videos that have been uploaded to the site. Will be making multiple videos covering everything you could ever want to know about…
December 5th, 2021
– Orphan-drug designation follows fast track designation granted to INBRX-109 in conventional chondrosarcoma
– Preliminary median progression-free survival (PFS) of 7.4 months and disease control rate of 89% observed in conventional chondrosarcoma…
November 23rd, 2021
View ORCID ProfileWilliam Cross, Iben Lyskjær, Tom Lesluyes, Steven Hargreaves, Anna-Christina Strobl, Christopher Davies, Sara Waise, Shadi Hames, Dahmane Oukrif, Hongtao Ye, Fernanda Amary, Roberto Tirabosco, Toby Baker, David Barnes,…
November 22nd, 2021
In our on-going effort to promote more research, clinical trials, improve treatment and seek a cure for Chondrosarcoma, the CS Foundation is in the process of establishing a contractual partnership with NORD: National Organization for Rare Disorders…
November 21st, 2021
by Lyubomir Haralambiev
1,2,*, Andreas Nitsch
1, Josephine M. Jacoby
1, Silas Strakeljahn
1, Sander Bekeschus
3, Alexander Mustea
4, Axel Ekkernkamp
1,2 and Matthias B. Stope
4
1
Department of Trauma, Reconstructive Surgery and Rehabilitation…
November 12th, 2021
Rose Truong Paderanga
Hi all- I was recently featured on the local news for the surgery for my chondrosarcoma and wanted to share… Medical advancements are happening all the time guys. Don’t give up hope. We’re in this together. …
TBX3 in Combination with c-Myc and Nucleolin as Multiple Markers for the Early Detection of Sarcomas
November 2nd, 2021
Project ended 30 June 2020 Prof Sharon Prince Department of Human Biology/Division of Cell Biology, University of Cape Town
Email Title of the project
TBX3 in combination with c-Myc and Nucleolin as multiple markers for the early…
November 1st, 2021
TBX3 in Combination with c-Myc and Nucleolin as Multiple Markers for the Early Detection of Sarcomas Project ended 30 June 2020 Prof Sharon Prince Prof Sharon Prince Department of Human Biology/Division of Cell Biology, University of Cape…
October 14th, 2021
A research project funded by the Bone Cancer Research Trust has found a promising clinical biomarker that offers pathologists an accurate and reproducible test to diagnose and stage chondrosarcoma, informing clinical management and deciding the type…